Reagents for testing.

Ended Awarded Last action

Contract number
HT009026FG0330013
Awardee
Awarding agency
Obligated
$49,611

Award facts

Contract value 100% obligated
$49,610.91 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
North Chicago, IL 60064, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Health Agency issued a BPA call to Abbott Laboratories Inc., Abbott Diagnostics Division, for reagents for testing, with a ceiling value of $49,610.91 and an award date of March 18, 2026. The call is performance-based through September 30, 2026, at the awardee's facility in North Chicago, Illinois. The source does not identify the parent BPA by name or contracting agency.

Quick answers

Who was awarded contract HT009026FG0330013?

HT009026FG0330013 was awarded to Abbott Laboratories Inc. by Defense Health Agency (Department of Defense) on March 18, 2026.

How much is contract HT009026FG0330013 worth?

The government has obligated $49,611 on HT009026FG0330013.

Is contract HT009026FG0330013 an order under another contract?

Yes. HT009026FG0330013 is a BPA call under FA301624A0044, a blanket purchase agreement.

Was contract HT009026FG0330013 competed?

The extent of competition for HT009026FG0330013 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award